Genome to kinome: Species-specific peptide arrays for kinome analysis

Science Signaling

Volumn 2, Issue 54, 2009, Pages

  Jalal, Shakiba ^a,b   Arsenault, Ryan ^a,b   Potter, Andrew A ^a   Babiuk, Lorne A ^c   Griebel, Philip J ^a   Napper, Scott ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CD14 ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; PHOSPHOSPECIFIC ANTIBODY; TOLL LIKE RECEPTOR 4; ADENOSINE TRIPHOSPHATE; ANTIBODY; PEPTIDE; PROTEOME;

AMINO ACID SEQUENCE; CELL CULTURE; CELL ISOLATION; CELL LABELING; CELL LYSATE; CELL SORTER; CONSENSUS; CULTURE MEDIUM; DATA BASE; FLOW CYTOMETRY; GENE CONSTRUCT; GENOME; GENOME ANALYSIS; HUMAN; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; REPRODUCIBILITY; REVIEW; VEIN PUNCTURE; ANIMAL; ARTICLE; BIOCHEMISTRY; BIOLOGICAL MODEL; BIOLOGY; CATTLE; CHEMISTRY; METABOLISM; METHODOLOGY; MOUSE; PHOSPHORYLATION;

ANIMALIA;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIBODIES; BIOCHEMISTRY; CATTLE; COMPUTATIONAL BIOLOGY; GENOME; HUMANS; MICE; MODELS, BIOLOGICAL; MONOCYTES; PEPTIDES; PHOSPHORYLATION; PROTEOME;

EID: 62349135257     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.254pl1     Document Type: Review

References (28)

1. G. Manning, D. B. Whyte, R. Martinez, T. Hunter, S. Sudarsanam, The protein kinase complement of the human genome. Science 298, 1912-1934 (2002).
2. P. Cohen, Protein kinases - the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1, 309-315 (2002).
3. Z. Songyang, K. L. Carraway, M. Eck, S. C. Harrison, R. A. Feldman, M. Mohammadi, J. Schlessinger, S. R. Hubbard, D. P. Smith, C. Eng, M. J. Lorenzo, B. A. J. Ponder, B. J. Mayer, L. C. Cantley, Catalytic specificity of protein-tyrosine kinases is critical for selective signaling. Nature 373, 536-539 (1995).
4. B. E. Kemp, D. B. Bylund, T. S. Huang, E. G. Krebs, Substrate specificity of the cyclic AMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A. 72, 3448-3452 (1975).
5. O. Zetterqvist, U. Ragnarsson, E. Humble, L. Berglund, L. Engstrom, The minimum substrate of cyclic AMP-stimulated protein kinase, as studied by synthetic peptides representing the phosphorylatable site of pyruvate kinase (type L) of rat liver. Biochem.Biophys.Res. Commun. 70, 696-703 (1976).
6. B. E. Kemp, D. J. Graves, E. Benjamini, E. G. Krebs, Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase. J. Biol. Chem. 252, 4888-4894 (1977).
7. B. T. Houseman, M. Mrksich, Towards quantitative assays with peptide chips: A surface engineering approach. Trends Biotechnol. 20, 279-281 (2002).
8. B. T. Houseman, J. H. Huh, S. J. Kron, M. Mrksich, Peptide chips for the quantitative evaluation of protein kinase activity. Nat. Biotechnol. 20, 270-274 (2002).
9. S. H. Diks, K. Kok, T. O'Toole, D. W. Hommes, P. van Dijken, J. Joore, M. P. Peppelenbosch, Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells. J. Biol. Chem. 279, 49206-49213 (2004).
10. J. W. van Baal, S. H. Diks, R. J. Wanders, A. M. Rygiel, F. Milano, J. Joore, J. J. Bergman, M. P. Peppelenbosch, K. K. Krishnadath, Comparison of kinome profiles of Barrett's esophagus with normal squamous esophagus and normal gastric cardia. Cancer Res. 66, 11605-11612 (2006).
11. M. Lowenberg, J. Tuynman, J. Bilderbeek, T. Gaber, F. Buttgereit, S. van Deventer, M. Peppelenbosch, D. Hommes, Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood 106, 1703-1710 (2005).
12. M. H. de Borst, S. H. Diks, J. Bolbrinker, M. W. Schellings, M. P. van Dalen, M. P. Peppelenbosch, R. Kreutz, Y. M. Pinto, G. Navis, H. van Goor, Profiling of the renal kinome: A novel tool to identify protein kinases involved in angiotensin II-dependent hypertensive renal damage. Am. J. Physiol. Renal Physiol. 293, F428-F437 (2007).
13. S. Caenepeel, G. Charydczak, S. Sudarsanam, T. Hunter, G. Manning, The mouse kinome: Discovery and comparative genetics of all mouse protein kinases. Proc. Natl. Acad. Sci. U.S.A. 101, 11707-11712 (2004).
14. V. Gerdts, S. van den Hurk, P. Griebel, L. Babiuk, Use of animal models in the development of human vaccines. Future Med. 2, 667-675 (2007).
15. S. van Drunen Littel-van den Hurk, S. L. Babiuk, L. A. Babiuk, Strategies for improved formulation and delivery of DNA vaccines to veterinary target species. Immunol. Rev. 199, 113-125 (2004).
16. Z. Dincer, S. Jones, R. Haworth, Preclinical safety assessment of a DNA vaccine using particle-mediated epidermal delivery in domestic pig, minipig and mouse. Exp. Toxicol. Pathol. 57, 351-357 (2006).
17. W. R. Hein, P. J. Griebel, A road less travelled: Large animal models in immunological research. Nat. Rev. Immunol. 3, 79-85 (2003).
18. S. Elahi, R. Brownlie, J. Korzeniowski, R. Buchanan, B. O'Connor, M. S. Peppler, S. A. Halperin, S. F. Lee, L. A. Babiuk, V. Gerdts, Infection of newborn piglets with Bordetella pertussis: A new model for pertussis. Infect. Immun. 73, 3636-3645 (2005).
19. S. Jalal, J. Kindrachuk, S. Napper, Phosphoproteome and kinome analysis: Unique perspectives on the same problem. Curr. Anal. Chem. 3, 1-15 (2007).
20. S. Akira, K. Takeda, Toll-like receptor signaling. Nat. Rev. Immunol. 4, 499-511 (2004).
21. C. Kollewe, A. C. Mackensen, D. Neumann, J. Knop, S. Li, H. Wesche, M. U. Martin, Sequential phosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling. J. Biol. Chem. 279, 5227-5236 (2004).
22. S. Hou, H. Guan, R. P. Richard, Phosphorylation of serine 337 of NF-κB p50 is critical for DNA binding. J. Biol. Chem. 278, 45994-45998 (2003).
23. G. Xiao, E. W. Harhaj, S. J. Sun, NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell 7, 401-409 (2001).
24. L. F. Chen, S. A. Williams, Y. Mu, H. Nakano, J. M. Duerr, L. Buckbinder, W. C. Greece, NF-κB RelA phosphorylaton regulates RelA acetylation. Mol. Cell. Biol. 25, 7966-7975 (2005).
25. M. J. Servant, N. Grandvaux, B. R. Tenover, D. Duguay, R. Lin, J. Hiscott, Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J. Biol. Chem. 278, 9441-9447 (2003).
26. N. Mookherjee, H. L. Wilson, S. Doria, Y. Popowych, R. Falsafi, J. J. Yu, S. Veatch, F. M. Roche, K. L. Brown, F. S. Brinkman, K. Hokamp, A. Potter, L. A. Babiuk, P. J. Griebel, R. E. Hancock, Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide. J. Leukoc. Biol. 80, 1563-1574 (2006).
27. M. Mann, S. E. Ong, M. Gronborg, H. Steen, O. N. Jensen, A. Pandey, Analysis of protein phosphorylation using mass spectrometery: Deciphering the phosphoproteome. Trends Biotechnol. 20, 261-268 (2002).
28. D. E. Kalume, H. Molina, A. Pandey, Tackling the phosphoproteome: Tools and strategies. Curr. Opin. Chem. Biol. 7, 64-69 (2003).